跳至主要内容
临床试验/NCT02764606
NCT02764606招募中不适用

CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
1
主要终点
The Serum levels of osteoprotegerin

研究概览

简要总结

CANPOS is a non-interventional study aiming at evaluate at the time of initial surgery the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer. This would represent a rational to develop personalized follow-up and prevention strategies

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a diagnosis or suspected for a diagnosis of lung cancer, non-small cell lung cancer
  • age over 18 years
  • patient naïve of any oncology treatment (excluding surgery alone) within the past 5 years
  • patient who signed the informed consent by the study protocol
  • Exclusion criteria were:
  • any ongoing treatment for cancer
  • any history of cancer within 5 years before the diagnosis of lung cancer
  • any psychological, sociological or geographical conditions that would not allow the study follow-up

排除标准

  • 未提供

结局指标

主要结局

The Serum levels of osteoprotegerin

时间窗: At the time of initial surgery

The serum levels of osteoprotegerin, as assessed by standard ELISA methods, will be measured to to evaluate at the time of initial surgery, the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验